This statement sets out the steps Releaf Dispensary Ltd (“Releaf”) has taken during the financial year ending 31 May 2026 to prevent modern slavery and human trafficking in our business and supply chains. It is made under section 54 of the Modern Slavery Act 2015.
Releaf takes a zero-tolerance approach to modern slavery. As a CQC regulated and certified B Corp, we hold ourselves to high standards in how we treat our patients, our people and everyone in our supply chain.
Our structure, business and supply chains
Releaf is a UK-based private medical cannabis clinic, regulated by the Care Quality Commission. We help patients access prescribed cannabis-based medicines through specialist clinicians and our own patient platform. We are a fully remote business with a team of more than 170, including contracted specialist prescribers, who are registered with the GMC or GPhC.
Our main supply chains are:
Medicinal cannabis products: imported products, including those cultivated and processed throughout Europe and sourced through import partners, and UK-grown products from our supply partner Glass Pharms. We also work with joint venture (JV) partners.
Packaging and labelling: suppliers in the UK, the EU and China.
Logistics and delivery: national delivery partners, including DPD and Royal Mail.
Goods and services: merchandise, office equipment, IT, software, professional services and recruitment agencies, mainly based in the UK.
Our policies
Our commitment is set out in these policies, which apply to all employees, workers, contractors and, where relevant, our suppliers:
Modern Slavery Policy: our zero-tolerance commitment, how we manage risk in our supply chains, and how to raise concerns. Our Board has overall responsibility for it.
Supplier Code of Conduct: sets the labour standards we expect from suppliers. It bans forced, bonded and child labour, recruitment fees and the retention of identity documents, and requires fair pay and safe working conditions. It also gives us the right to request evidence and carry out audits.
Whistleblowing Policy and Freedom to Speak Up Guardians: employees, workers, suppliers and their staff can raise concerns confidentially, without fear of retaliation.
Recruitment and right-to-work checks: we carry out right-to-work checks for every hire, whatever the source, and pay all employees through traceable PAYE payroll.
Assessing and managing risk
Our highest risks sit in overseas cultivation, processing and packaging, where we have less visibility beyond our import partners. In September 2026, we completed a modern slavery risk assessment covering our own workforce and our direct Tier 1 suppliers, and, where we have visibility, Tier 2 suppliers. We rated each area on likelihood and impact, taking into account sector, location, business model and commercial pressures.
We will review the assessment at least once a year, and sooner if our supply chain changes, for example if we take on a new import supplier or outsourced service.
Due diligence
We focus our due diligence where our risk assessment shows the greatest risk. Our approach includes:
Carrying out checks on new suppliers and partners before we work with them.
Asking suppliers to sign our Supplier Code of Conduct, and including anti-slavery clauses in contracts where appropriate.
Reserving the right to request evidence, questionnaires and audits, and to act if standards aren’t met, up to ending the relationship.
Keeping right-to-work checks in-house for every hire, including those through agencies.
Training
We train the people most likely to come across modern slavery risk, so they can recognise the signs and know how to act. In 2026 colleagues in procurement, supply chain and people management completed modern slavery awareness training. All employees can find our Modern Slavery Policy and how to raise a concern on our internal intranet and Employee Handbook.
Measuring effectiveness
We track these indicators to measure our progress, and will report against them in next year’s statement.
